Form 8-K Filing: SRx Health Solutions, Inc. Renames to EMJX, Inc. and Approves Major Transaction

On December 17, 2025, SRx Health Solutions, Inc. (the "Company") held a stockholder vote by written consent to approve several key matters. The stockholders approved the change of the Company's legal name from "SRx Health Solutions, Inc." to "EMJX, Inc." and its NYSE ticker symbol from "SRXH" to "EMJX," contingent upon the closing of a significant transaction. This transaction involves the acquisition of EMJ Crypto Technologies Inc. and its associated intellectual property, including an AI-driven algorithm for predicting trading outcomes. The Company also received approval to increase the number of shares under its 2019 Incentive Award Plan, appoint four new directors (Simon Conway, Michael Young, Joshua A. Epstein, and Sammy Dorf), approve the compensation of named executive officers on a non-binding advisory basis, and ratify the appointment of Davidson and Company LLP as its independent registered public accountant for 2025. The affirmative vote of one-third of the Company's outstanding voting capital stock was required for approval, with stockholders representing 45.42% of the voting power consenting to these changes. The Company will file an information statement on Schedule 14C with the SEC prior to finalizing these actions.